Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model

Pharmaceutical Research

Volumn 24, Issue 5, 2007, Pages 955-962

  Mei, Lin ^a   Sun, Hongfan ^a   Jin, Xu ^a   Zhu, Dunwan ^a   Sun, Rui ^b   Zhang, Minfang ^b   Song, Cunxian ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

DMAB; Nanoparticle; Paclitaxel; Restenosis; Surface modification

Indexed keywords

CATIONIC SURFACTANT; DIDODECYLDIMETHYLAMMONIUM BROMIDE; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY INJURY; CHEMICAL MODIFICATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RELEASE; MORPHOMETRICS; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SURFACE CHARGE; SURFACE PROPERTY; TREATMENT OUTCOME; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BALLOON DILATATION; CAROTID ARTERY INJURIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERPLASIA; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYGLACTIN 910; POLYVINYL ALCOHOL; RABBITS; SOLUBILITY; TIME FACTORS; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 34247639105     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9214-z     Document Type: Article

References (42)

1. J. A. Bittl. Advances in coronary angioplasty. N. Engl. J. Med. 335:1290-1302 (1996).
2. U. Westedt, L. Barbu-Tudoran, A. K. Schaper, M. Kalinowsk, H. Alfke, and T. Kissel. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS PharmSci 4(4), 1-6 (2004).
3. G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, C. Wong, M. K. Hong, J. A. Kovach, and M. B. Leon. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94(1), 35-43 (1996).
4. T. Kimura, S. Kaburagi, T. Tamura, H. Yokoi, Y. Nakagawa, H. Yokoi, N. Hamasaki, H. Nosaka, M. Nobuyoshi, G. S. Mintz, J. J. Popma, and M. B. Leon. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 96(2), 475-483 (1997).
5. H. Hanke, T. Strohschneider, M. Oberhoff, E. Betz, and K. R. Karsch. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res. 67(3), 651-659 (1990).
6. Y. Shi, J. E. O'Brien, L. Ala-Kokko, W. Chung, J. D. Mannion, and A. Zalewski. Origin of extracellular matrix synthesis during coronary repair. Circulation 95(4), 997-1006 (1997).
7. C. Hehrlein, C. Gollan, K. Donges, J. Metz, R. Riessen, P. Fehsenfeld, E. Hodenbergvon, and W. Kubler. Low -dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 92(6), 1570-1575 (1995).
8. E. Regar, G. Sianos, and P. W. Serruys. Stent development and local drug delivery. Br. Med. Bull. 59(1), 227-248 (2001).
9. E. Grube, S. Silber, K. E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, and M. E. Russell. TAXUS I: six-and 12-month results from a randomized, double-blind trial on a slow-release paclitaxeleluting stent for de novo coronary lesions. Circulation 107:38-42 (2003).
10. S. J. Park, W. H. Shim, D. S. Ho, A. E. Raizner, S. W. Park, M. K. Hong, C. W. Lee, D. Choi, Y. Jang, R. Lam, N. J. Weissman, and G. S. Mintz. A paclitaxel-eluting stent for the prevention of coronary restenosis. N. Engl. J. Med. 348:1537-1545 (2003).
11. J. W. Moses, M. B. Leon, J. J. Popma, P. J. Fitzgerald, D. R. Holmes, C. O'Shaughnessy, R. P. Caputo, D. J. Kereiakes, D. O. Williams, P. S. Teirstein, J. L. Jaeger, and R. E. Kuntz. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349:1315-1323 (2003).
12. S. Banai, M. Chorny, S. D. Gertz, I. Fishbein, J. Gao, L. Perez, G. Lazarovichi, A. Gazit, A. Levitzki, and G. Golomb. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 26:4898-4901 (2005).
13. H. Wolinsky and S. N. Thung. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 15(2), 475-481 (1990).
14. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Böhm, and G. Nickenig. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7), 810-814 (2004).
15. D. W. Muller, E. J. Topol, G. D. Abrams, K. P. Gallagher, and S. G. Ellis. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J. Am. Coll. Cardiol. 20(2), 460-466 (1992).
16. T. L. Lambert, V. Dev, E. Rechavia, J. S. Forrester, F. Litvack, and N. L. Eigler. Localized arterial wall drug delivery from a polymer-coated removable metallic stent: kinetics, distribution, and bioactivity of forskolin. Circulation 90(2), 1003-1011 (1994).
17. F. Valero, M. Hamon, C. Fournier, T. Meurice, B. Flautre, E. Van Belle, J. M. Lablanche, B. Gosselin, C. Bauters, and M. Bertrand. Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. J. Cardiovasc. Pharmacol. 31(4), 513-519 (1998).
18. R. L. Wilensky, K. L. March, I. Gradus-Pizlo, D. Schauwecker, M. B. Michaels, J. Robinson, K. Carlson, and D. R. Hathaway. Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am. Heart J. 129(5), 852-859 (1995).
19. L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol. Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441-1448 (1996).
20. C. X. Song, V. Labhasetwar, H. Murphy, X. Qu, W. R. Humphrey, R. J. Shebuski, and R. J. Levy. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release 43:197-212 (1997).
21. V. Labhasetwar, C. Song, and R. J. Levy. Nanoparticle drug delivery system for restenosis. Adv. Drug Deliv. Rev. 24:63-85 (1997).
22. W. R. Humphrey, L. A. Erickson, C. A. Simmons, J. L. Northrup, D. G. Wishka, J. Morris, V. Labhasetwar, C. Song, R. J. Levy, and R. J. Shebuski. The effect of intramural delivery of polymeric nanoparticles loaded with the anti-proliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary. Adv. Drug Deliv. Rev. 24:87-108 (1997).
23. C. Song, V. Labhasetwar, X. Cui, T. Underwood, and R. J. Levy. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J. Control. Release 54(2), 201-211 (1998).
24. V. Labhasetwar, C. Song, W. Humphrey, R. Shebuski, and R. J. Levy. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87(10), 1229-1234 (1998).
25. K. R. Kamath, J. J. Barry, and K. M. Miller. The Taxus™ druge-luting stent: a new paradigm in controlled drug delivery. Adv. Drug Deliv. Rev. 58(3), 412-436 (2006).
26. D. W. Kim, J. S. Kwon, Y. G. Kim, M. S. Kim, G. S. Lee, T. J. Youn, and M. C. Cho. Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. Circulation 109:1558-1563 (2004).
27. T. K. Nasser, R. L. Wilensky, K. Mehdi, and K. L. March. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy. Am. Heart J. 131(5), 892-898 (1996).
28. J. J. Rome, V. Shayani, M. Y. Flugelman, K. D. Newman, A. Farb, R. Virmani, and D. A. Dichek. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler. Thromb. 14:148-161 (1994).
29. J. M. Anderson and M. S. Shive. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28:5-24 (1997).
30. I. Gradus-Pizlo, R. L. Wilensky, K. L. March, N. Fineberg, M. Michaels, G. E. Sandusky, and D. R. Hathaway. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. J. Am. Coll. Cardiol. 26(6), 1549-1557 (1995).
31. V. Dev, N. Eigler, M. C. Fishbein, Y. Tian, A. Hickey, E. Rechavia, J. S. Forrester, and F. Litvack. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Catheter. Cardiovasc. Diagn. 41(3), 324-332 (1997).
32. L. A. M. Rupert, D. Hoekstra, and B. F. N. Engberts. Fusogenic behavior of didodecyldimethylammonium bromide bilayer vesicles. J. Am. Chem. Soc. 107:2628-2631 (1985).
33. H. Suh, B. Jeong, R. Rathi, and S. W. Kim. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly (ethyleneoxide)-poly(lactide/ glycolide) nanospheres. J. Biomed. Mater. Res. 42:331-338 (1998).
34. J. K. Jackson, K. C. Skinner, L. Burgess, T. Sun, W. L. Hunter, and H. M. Burt. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm. Res. 19:411-417 (2002).
35. N. Kunou, Y. Ogura, M. Hashizoe, Y. Honda, S. H. Hyon, and Y. Ikada. Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits. J. Control. Release 37:143-150 (1995).
36. C. G. Pitt, M. M. Gratzl, A. R. Jeffcoat, R. Zweidinger, and A. Schindler. Sustained drug delivery systems. II. Factors affecting release rates from poly(ε-caprolactone) and related biodegradable polymers. J. Pharm. Sci. 68:1534-1538 (1979).
37. M. S. Hora, R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley, and M. E. Hudson. Release of human serum albumin from retinitis with intravitreal injection of liposome encapsulated poly(lactide-co-glycolide) microspheres. Pharm. Res. 7:1190-1194 (1990).
38. T. Yasukawa, H. Kimura, Y. Tabata, and Y. Ogura. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52:25-36 (2001).
39. J. Panyam, M. M. Dali, S. K. Sahoo, W. Ma, S. S. Chakravarthi, G. L. Amidon, R. J. Levy, and V. Labhasetwar. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. J. Control. Release 92:173-187 (2003).
40. L. Manil, J. Davin, C. Duchenne, C. Kubiak, J. Foidart, P. Couvreur, and P. Mahieu. Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro. Pharm. Res. 11:1160-1167 (1994).
41. J. J. Wright and L. Illum. Active targeting of microcapsules and microspheres to specific regions. In M. Donbrow (ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 282-293.
42. J. You, M. Kamihira, and S. Iijima. Surfactant-mediated gene transfer for animal cells. Cytotechnology 25:45-52 (1997).